ANDA 75717, held by Apotex Inc. Albuterol Sulfate.
As of Nov 16, 2026, ANDA 75717 (Albuterol Sulfate), held by Apotex Inc, was first approved by FDA on Feb 2, 2007, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 2, 2007 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Albuterol SulfateEQ 0.083% BASE ยท solution;inhalation | Albuterol Sulfate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters